409
Views
8
CrossRef citations to date
0
Altmetric
Reviews

Imaging of perianal fistulizing Crohn’s disease

&

References

  • Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn’s disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008;103(12):3082-93
  • Sides C, Trinidad MC, Heitlinger L, Anasti J. Crohn disease and the gynecologic patient. Obstet Gynecol Surv 2013;68(1):51-61
  • Compton GL, Bartlett M. Perianal disease in pediatric Crohn disease: a review of MRI findings. Pediatr Radiol 2014;44(10):1198-208; quiz 1195-1197
  • Haennig A, Lepage B, Staumont G, et al. Major role of sustained drainage in the management of Fistulizing Perianal Crohn’s disease under anti-TNF therapy: a cohort study of 81 patients with successful long term follow-up. Gastroenterology 2011;140(5):S-281
  • Hellers G, Bergstrand O, Ewerth S, Holmstrom B. Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease. Gut 1980;21(6):525-7
  • Schwartz DA, Loftus EVJr, Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 2002;122(4):875-80
  • Lapidus A. Crohn’s disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006;12(1):75-81
  • Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn’s disease? A population-based study. Clin Gastroenterol Hepatol 2006;4(9):1130-4
  • Lockhart-Mummery HE. Symposium. Crohn’s disease: anal lesions. Dis Colon Rectum 1975. 18(3):200-2
  • de Zoeten EF, Pasternak BA, Mattei P, et al. Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr 2013;57(3):401-12
  • Nordgren S, Fasth S, Hulten L. Anal fistulas in Crohn’s disease: incidence and outcome of surgical treatment. Int J Colorectal Dis 1992;7(4):214-18
  • Schwartz DA, White CM, Wise PE, Herline AJ. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn’s perianal fistulas. Inflamm Bowel Dis 2005;11(8):727-32
  • Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999;340(18):1398-405
  • Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976;63(1):1-12
  • American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn’s disease. Gastroenterology 2003;125(5):1503-7
  • Goligher JC. Fistula-in-ano: management of perianal suppuration. Dis Colon Rectum 1976;19(6):516-17
  • Bell SJ, Williams AB, Wiesel P, et al. The clinical course of fistulating Crohn’s disease. Aliment Pharmacol Ther 2003;17(9):1145-51
  • Holzheimer RG, Mannick JA. Surgical Treatment: evidence-based and problem oriented. Part V Anal. Zuckschwerdt, Munich; 2001. p. 234-9
  • Bailey HR, Billingham RP, Stamos MJ, et al. Colorectal Surg. Chapter 8, Abscess and Fistula, 2013. p. 129-46
  • Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology 2001;121(5):1064-72
  • Halligan S, Stoker J. Imaging of fistula in ano. Radiology 2006;239(1):18-33
  • Wise PE, Schwartz DA. The evaluation and treatment of Crohn perianal fistulae: EUA, EUS, MRI, and other imaging modalities. Gastroenterol Clin North Am 2012;41(2):379-91
  • Kuijpers HC, Schulpen T. Fistulography for fistula-in-ano. Is it useful? Dis Colon Rectum 1985;28(2):103-4
  • Caliste X, Nazir S, Goode T, et al. Sensitivity of computed tomography in detection of perirectal abscess. Am Surg 2011;77(2):166-8
  • Mackalski BA, Bernstein CN. New diagnostic imaging tools for inflammatory bowel disease. Gut 2006;55(5):733-41
  • Hsieh J. Spie. Computed tomography: principles, design, artifacts, and recent advances. Wiley Interscience; SPIE Press; Hoboken, N.J; Bellingham, Wash: 2009
  • Ardizzone S, Maconi G, Cassinotti A, et al. Imaging of perianal Crohn’s disease. Dig Liver Dis 2007;39(10):970-8
  • Papadia C, Maffei E, Del Rio P, et al. Sensitivity and specificity of magnetic resonance enterography in the clinical management of fistulizing Crohn’s disease. Inflamm Bowel Dis 2013;19(9):1896-903
  • Kidd R, Mezwa DG, Ralls PW, et al. Imaging recommendations for patients with newly suspected Crohn’s disease, and in patients with known Crohn’s disease and acute exacerbation or suspected complications. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(Suppl):181-92
  • Horsthuis K, Stoker J. MRI of perianal Crohn’s disease. AJR Am J Roentgenol 2004;183(5):1309-15
  • de Miguel Criado J, del Salto LG, Rivas PF, et al. MR imaging evaluation of perianal fistulas: spectrum of imaging features. Radiographics 2012;32(1):175-94
  • Shenoy-Bhangle A, Nimkin K, Goldner D, et al. MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatr Radiol 2014;44(1):23-9
  • Morris J, Spencer JA, Ambrose NS. MR imaging classification of perianal fistulas and its implications for patient management. Radiographics 2000;20(3):623-35; discussion 635-627
  • de la Poza G, Lopez-Sanroman A, Taxonera C, et al. Genital fistulas in female Crohn’s disease patients: clinical characteristics and response to therapy. J Crohns Colitis 2012;6(3):276-80
  • Ng SC, Plamondon S, Gupta A, et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol 2009;104(12):2973-86
  • Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol 2003;98(2):332-9
  • Karmiris K, Bielen D, Vanbeckevoort D, et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn’s disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 2011;9(2):130-6
  • Singh K, Singh N, Thukral C, et al. Magnetic resonance imaging (MRI) evaluation of perianal fistulae with surgical correlation. J Clin Diagn Res 2014;8(6):RC01-4
  • Maccioni F, Al Ansari N, Mazzamurro F, et al. Detection of Crohn disease lesions of the small and large bowel in pediatric patients: diagnostic value of MR enterography versus reference examinations. AJR Am J Roentgenol 2014;203(5):W533-42
  • Tozer P, Ng SC, Siddiqui MR, et al. Long-term MRI-guided combined anti-TNF-alpha and thiopurine therapy for Crohn’s perianal fistulas. Inflamm Bowel Dis 2012;18(10):1825-34
  • Szurowska E, Wypych J, Izycka-Swieszewska E. Perianal fistulas in Crohn’s disease: MRI diagnosis and surgical planning: MRI in fistulizing perianal Crohn’s disease. Abdom Imaging 2007;32(6):705-18
  • Mian N, Kaushik N. The role of endoscopic ultrasound in perianorectal Crohn’s disease. Pract Gastroenterol 2007;31(8):45-50
  • West NE, Schwartz DA. The role of endoscopic ultrasound in the treatment of Crohn’s perianal fistulas. Pract Gastroenterol 2006;30(5):37-44
  • Zawadzki A, Starck M, Bohe M, Thorlacius H. A unique 3D endoanal ultrasound feature of perianal Crohn’s fistula: the ’Crohn ultrasound fistula sign’. Colorectal Dis 2012;14(9):e608-11
  • Zbar AP, Horesh N, Bucholtz V, et al. Are there specific endosonographic features in Crohn’s patients with perianal fistulae? J Crohns Colitis 2013;7(6):490-6
  • Nevler A, Beer-Gabel M, Lebedyev A, et al. Transperineal ultrasonography in perianal Crohn’s disease and recurrent cryptogenic fistula-in-ano. Colorectal Dis 2013;15(8):1011-18
  • Maconi G, Ardizzone S, Greco S, et al. Transperineal ultrasound in the detection of perianal and rectovaginal fistulae in Crohn’s disease. Am J Gastroenterol 2007;102(10):2214-19
  • Tsankov T, Tankova L, Deredjan H, Kovatchki D. Contrast-enhanced endoanal and transperineal sonography in perianal fistulas. Hepatogastroenterology 2008;55(81):13-16
  • Schratter-Sehn AU, Lochs H, Vogelsang H, et al. Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn’s disease. Endoscopy 1993;25(9):582-6
  • Maconi G, Tonolini M, Monteleone M, et al. Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn’s disease. Inflamm Bowel Dis 2013;19(13):2737-43
  • Patel NS, Pola S, Muralimohan R, et al. Outcomes of computed tomography and magnetic resonance enterography in clinical practice of inflammatory bowel disease. Dig Dis Sci 2014;59(4):838-49
  • Seastedt KP, Trencheva K, Michelassi F, et al. Accuracy of CT enterography and magnetic resonance enterography imaging to detect lesions preoperatively in patients undergoing surgery for Crohn’s disease. Dis Colon Rectum 2014;57(12):1364-70
  • Sofic A, Beslic S, Sehovic N, et al. MRI in evaluation of perianal fistulae. Radiol Oncol 2010;44(4):220-7
  • Liang C, Jiang W, Zhao B, et al. CT imaging with fistulography for perianal fistula: does it really help the surgeon? Clin Imaging 2013;37(6):1069-76
  • Gee MS, Harisinghani MG. MRI in patients with inflammatory bowel disease. J Magn Reson Imaging 2011;33(3):527-34
  • Lahat A, Assulin Y, Beer-Gabel M, Chowers Y. Endoscopic ultrasound for perianal Crohn’s disease: disease and fistula characteristics, and impact on therapy. J Crohns Colitis 2012;6(3):311-16
  • Savoye-Collet C, Savoye G, Koning E, et al. Fistulizing perianal Crohn’s disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis 2011;17(8):1751-8
  • Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut 2014;63(9):1381-92
  • Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7(7):556-85
  • Perez-Rodriguez J, Lai S, Ehst BD, et al. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment–report of 33 cases. Radiology 2009;250(2):371-7
  • Wang Y, Alkasab TK, Narin O, et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 2011;260(1):105-11
  • Hagele J, Simon M. [Nephrogenic systemic fibrosis (NSF): effects of stricter guidelines on the use of contrast media containing gadolinium]. Radiologe 2011;51(10):831-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.